254 related articles for article (PubMed ID: 23292955)
1. Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer.
Vermeer DW; Spanos WC; Vermeer PD; Bruns AM; Lee KM; Lee JH
Int J Cancer; 2013 Jul; 133(1):120-9. PubMed ID: 23292955
[TBL] [Abstract][Full Text] [Related]
2. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
[TBL] [Abstract][Full Text] [Related]
3. HPV-induced oropharyngeal cancer, immune response and response to therapy.
Vu HL; Sikora AG; Fu S; Kao J
Cancer Lett; 2010 Feb; 288(2):149-55. PubMed ID: 19628331
[TBL] [Abstract][Full Text] [Related]
4. Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition.
Coppock JD; Wieking BG; Molinolo AA; Gutkind JS; Miskimins WK; Lee JH
Neoplasia; 2013 Jun; 15(6):620-30. PubMed ID: 23730210
[TBL] [Abstract][Full Text] [Related]
5. In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines.
Zhang M; Rose B; Lee CS; Hong AM
Cancer Biol Ther; 2015; 16(8):1231-40. PubMed ID: 26046692
[TBL] [Abstract][Full Text] [Related]
6. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
[TBL] [Abstract][Full Text] [Related]
7. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
8. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
9. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.
Mirghani H; Amen F; Tao Y; Deutsch E; Levy A
Cancer Treat Rev; 2015 Dec; 41(10):844-52. PubMed ID: 26476574
[TBL] [Abstract][Full Text] [Related]
10. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
[TBL] [Abstract][Full Text] [Related]
11. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
[TBL] [Abstract][Full Text] [Related]
12. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
Chen AM; Felix C; Wang PC; Hsu S; Basehart V; Garst J; Beron P; Wong D; Rosove MH; Rao S; Melanson H; Kim E; Palmer D; Qi L; Kelly K; Steinberg ML; Kupelian PA; Daly ME
Lancet Oncol; 2017 Jun; 18(6):803-811. PubMed ID: 28434660
[TBL] [Abstract][Full Text] [Related]
13. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of human papillomavirus in oropharyngeal carcinoma treated with radiotherapy: An updated systematic review and meta-analysis of 30 trials.
Petrelli F; Sarti E; Barni S
Head Neck; 2014 May; 36(5):750-9. PubMed ID: 23606404
[TBL] [Abstract][Full Text] [Related]
15. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
[TBL] [Abstract][Full Text] [Related]
16. Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature.
Saber CN; Grønhøj Larsen C; Dalianis T; von Buchwald C
Oral Oncol; 2016 Jul; 58():8-13. PubMed ID: 27311396
[TBL] [Abstract][Full Text] [Related]
17. B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Ukpo OC; Thorstad WL; Lewis JS
Head Neck Pathol; 2013 Jun; 7(2):113-21. PubMed ID: 23179191
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
19. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]